Brief: Kontafarma China Says Huang Yu Re-Designated To Non-Executive Director
19/04/2024 16:35
April 19 (Reuters) - Kontafarma China Holdings Ltd
1312.HK :
* HUANG YU RE-DESIGNATED FROM EXECUTIVE DIRECTOR TO
NON-EXECUTIVE
DIRECTOR
* HUANG YU WILL CONCURRENTLY CEASE TO BE PRESIDENT
* CHAI HONGJIE TO RETIRE AS EXECUTIVE DIRECTOR
* BAI PINGYAN DECIDED TO RETIRE AS EXECUTIVE DIRECTOR
* JIANG CHAOWEN TO RETIRE AS EXECUTIVE DIRECTOR
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr